Analysis of coagulability and coagulation factors before and after the development of symptoms in patients with physical urticaria

Analysis of coagulability and coagulation factors before and after the development of symptoms in patients with physical urticaria - Coagulability and coagulation factors before and after the development of urticaria

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002585

Enrollment

Registered

2009-10-05

Start date

2009-07-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

physical urticaria

Interventions

The provocation of urticarial symptoms

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with physical urticaria who 1. are not less than 20 years old (no upper limit) 2. gave written informed consent

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women or women of child bearing potential not using contraception 2. Patients with diseases as follows. Liver disease, psychological illness, convulsive and other seizure, heart disease, hemoglobinopathy, hemophilia, uncontrolled diabetes, and autoimmune diseases. 3. Patients who use medications that influence the coagulation and fibrinolytic cascade. 4. Others whom the physician judges are not suitable as subjects

Design outcomes

Primary

Measure	Time frame
Measurements regarding coagulability, coagulation factors and levels of blood histamine before and after the development of symptoms	—

Countries

Japan

Contacts

Public ContactSatoshi Morioke

Hiroshima University Hospital Department of Dermatology

morioke-hma@hiroshima-u.ac.jp082-257-5237

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026